Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.85 USD | +0.83% | +2.33% | +17.48% |
05-13 | Oppenheimer Adjusts Achieve Life Sciences Price Target to $11 From $18, Maintains Outperform Rating | MT |
05-09 | Transcript : Achieve Life Sciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.48% | 165M | |
+28.85% | 48.16B | |
-0.86% | 41.73B | |
+43.40% | 41.03B | |
-5.31% | 28.77B | |
+10.31% | 25.59B | |
-21.06% | 18.96B | |
+7.41% | 12.92B | |
+26.92% | 12.03B | |
-2.92% | 11.77B |
- Stock Market
- Equities
- ACHV Stock
- News Achieve Life Sciences, Inc.
- Oppenheimer Adjusts Achieve Life Sciences PT to $20 From $27 Given Difficult Current Market Conditions, Maintains Outperform Rating